Avita Therapeutics – Consensus Indicates Potential 71.6% Upside

Broker Ratings

Avita Therapeutics found using ticker (RCEL) now have 5 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 60 and 35 and has a mean target at 45.2. With the stocks previous close at 26.34 this would indicate that there is a potential upside of 71.6%. The 50 day moving average now sits at 20.09 and the 200 day MA is 23.14. The company has a market capitalisation of $584m. Find out more information at: http://www.avitamedical.com

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient’s own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits
Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:

    Twitter
    LinkedIn
    Facebook
    Email
    Reddit

      AIM All Share Index